20Oct
Driving Revenue And Deal Flow Through An Intelligent IP Strategy: Strategies For Smaller And Early-Stage Life Science Companies. Part III: Choosing The Right Transaction
Part I described various strategies to help smaller and early-stage life science companies establish an intelligent IP strategy and Part II described various strategies used when preparing for a transaction. In this Part III, we discuss the various relevant factors for choosing the right transaction......
By:
Adler Pollock & Sheehan P.C.
Related
Market Trends: What You Need to Know - As reflected in the American Bar Association's Private Targe...
Read More >
Turning a blind eye – one-off act not a PCP - In Ishola v Transport for London the Court of Appeal...
Read More >
By all accounts, 2019 proved to be another year of significant investment by private equity firms in...
Read More >
Recent insolvency law reforms in the UK, Singapore and Australia impact upon the ability of a party ...
Read More >
On July 2, 2019, New Jersey Governor Phil Murphy signed into law the Jake Honig Compassionate Use Me...
Read More >
The Department of Labor (DOL) published a Notice of Proposed Rulemaking (NPRM) on October 8, 2019, t...
Read More >